AGP Picks
View all

AGP Executive Report

Last update: 5 hours ago

Police Investigation: Judicial police searched the Bandim Health Project in Bissau and seized hepatitis B vaccine doses, saying the move is part of an investigation and does not establish any problem with the vaccines’ quality or safety. Trial Approval: Health Minister Quinhin Nantote says Guinea-Bissau has not authorized the controversial newborn study, despite researchers reporting ethics approvals. The proposed trial would delay the birth dose for half of 14,000 infants until six weeks of age, prompting concern about withholding protection against a serious infection.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Oct. 15, 2026

Stand Up for Science publishes Guinea-Bissau vaccine trial investigation

AGP

fallback image
Oct. 13, 2026

Stand Up for Science pushes Congress to halt CDC vaccine study in Guinea-Bissau

AGP

fallback image
Oct. 8, 2026

Stand Up for Science blasts CDC plan to revive Guinea-Bissau vaccine study

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service
Guinea-Bissau Has Not Approved Hep B Vaccine Trial in Newborns

Guinea-Bissau Has Not Approved Hep B Vaccine Trial in Newborns

Hepatitis B Guinea-Bissau trial: Researchers behind controversial study weigh in as confusion reigns over its fate

Hepatitis B Guinea-Bissau trial: Researchers behind controversial study weigh in as confusion reigns over its fate


fallback image
Oct. 15, 2026

As CDC Renews Controversial Guinea-Bissau Vaccine Trial, Stand Up for Science Makes Its Field Investigation Public

EIN Presswire

fallback image
Oct. 8, 2026

Stand Up for Science Condemns CDC’s Attempts to Restart Controversial Vaccine Study in Guinea-Bissau

EIN Presswire

fallback image
Oct. 13, 2026

Stand Up for Science Launches Petition to Halt CDC Vaccine Study in West Africa

EIN Presswire

fallback image
Feb. 22, 2026

Guinea-Bissau Stops Trump-Backed Hepatitis B Vaccine Study

MENAFN

fallback image
Feb. 22, 2026

Guinea-Bissau Stops US-Funded Hepatitis B Vaccine Trial

MENAFN

fallback image
Feb. 25, 2026

STAND UP FOR SCIENCE: CDC-FUNDED HEPATITIS B STUDY IN GUINEA-BISSAU CANCELLED

EIN Presswire

More press releases

Video Stories

YouTube video thumbnail:  CAS Verdict on Senegal AFCON Title Appeal 'Expected End November'
Play
CAS Verdict on Senegal AFCON Title Appeal 'Expected End November'
YouTube video thumbnail: Niger, Mali and Burkina Faso Resume Dialogue With Ecowas Regional Bloc
Play
Niger, Mali and Burkina Faso Resume Dialogue With Ecowas Regional Bloc
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Kenyan Cult Leader Found Guilty of Murder
Play
Kenyan Cult Leader Found Guilty of Murder
YouTube video thumbnail: Inside Ivory Coast's Cocoa Farms, Still Reeling From a 2024 Heat Storm
Play
Inside Ivory Coast's Cocoa Farms, Still Reeling From a 2024 Heat Storm

Video Title

Sign up for:

Guinea Bissau Health Bulletin

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Guinea Bissau Health Bulletin

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.